MedTrace Logo

Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia

NCT04069247 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 708

Last updated 2025-01-09

Study results available
· View outcomes & findings →

Summary

This study aims to conduct a randomized control trial to validate the treatment effect of e-based cognitive behavioral therapy for Insomnia (e-CBT-I) on insomnia disorder, and explore whether e-CBT-I could prevent depression and suicide in youths with insomnia and subclinical depression. In addition, to further explore the mechanisms underlying the association between insomnia treatments and psychiatric disorders, this study will evaluate whether changes in candidate factors including insomnia symptoms, poor sleep hygiene, sleep-related unhelpful thoughts and maladaptive behaviors, circadian rhythm disruption and chronic sleep deprivation will mediate the effect of e-CBT-I on prevention of depression and suicide.

Conditions

Interventions

BEHAVIORAL

e-CBT-I

The e-CBT-I will be delivered through a mobile application (eSleep) with a personal password.

BEHAVIORAL

e-HE

The e-HE will be delivered in control though a mobile application (eSleep) with a personal password.

Sponsors & Collaborators

  • Peking University Sixth Hospital

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Yun Kwok Wing, MBChB · Chinese University of Hong Kong

  • Lin Lu, PhD · Peking University Sixth Hospital

  • Shirley Xin Li, PhD · Hong Kong University

  • Jihui Zhang, PhD · Chinese University of Hong Kong

  • Le Shi, PhD · Peking University Sixth Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-05
Primary Completion
2024-01-18
Completion
2024-01-18

Countries

  • China
  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04069247 on ClinicalTrials.gov